Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the usual routine of online meetings and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in a better direction with a cup or three of stimulation. Today, we are reaching for hazelnut creme. As always, you are invited to join us. Meanwhile, here are a few items of interest to help you along. We hope you have a meaningful and productive day. And of course, do keep in touch. We appreciate feedback and tips. …
The U.S. Food and Drug Administration’s historic approval of the first gene therapies for sickle cell disease sparked discussion, debate, and, above all, measured optimism at this year’s meeting of the American Society of Hematology, STAT…
Click here to view original post
